Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease - Wikidata - awgldk - TriplyDB

Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease

Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease

http://www.wikidata.org/entity/Q35221777

about

Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease

http://www.wikidata.org/entity/Q35221777

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Effect of entacapone on colon ...... t model of Parkinson's disease

@ast

Effect of entacapone on colon ...... t model of Parkinson's disease

@en

type

label

Effect of entacapone on colon ...... t model of Parkinson's disease

@ast

Effect of entacapone on colon ...... t model of Parkinson's disease

@en

prefLabel

Effect of entacapone on colon ...... t model of Parkinson's disease

@ast

Effect of entacapone on colon ...... t model of Parkinson's disease

@en

P1433

Q35221777-78FC0597-F4B1-486D-B8E0-FF6733675ED3

P1476

Q35221777-5E3864D6-72CA-49E7-898E-76FFD893FEE7

P2093

Q35221777-00616F2F-A42D-4E8F-A768-1942FACF0ADC

Q35221777-009C9F2F-3D66-4F61-9F8B-043C75CAE351

Q35221777-0AB5E193-1486-42C0-AE52-CAD1DE4B17C0

Q35221777-2F4A0F0D-2B56-4C58-B480-A761DDEE7673

Q35221777-773C6A50-19EC-42CE-9504-9CE6EF09A404

Q35221777-D23320BF-EDBE-45A6-AF16-5CA17FCAA648

Q35221777-E81C43AB-D33F-4D08-9A89-5C624065AADC

P2860

Q35221777-15149D72-6EA1-488E-8D06-48734A3D63F0

Q35221777-24EB8AEA-A0AD-4978-B4E3-5E17D3622F24

Q35221777-2B61A3ED-36AF-4CBA-9250-7F311CD530C6

Q35221777-3840E740-8512-4E79-BC72-AB82C6B46719

Q35221777-389738B3-DF0F-454F-BA63-99849676A2D7

Q35221777-42EEBB68-29A8-4C6D-A159-71F561C3D787

Q35221777-47C20C5E-907D-4370-AACC-DB6688E481F9

Q35221777-49571B0B-CC95-4BC0-A8B4-0FEBD2CCB52C

Q35221777-4E474455-616E-4CD9-A9F5-C8FE89744ACD

Q35221777-50CC0449-1D4A-4816-ADA5-85054F3EC234

P304

Q35221777-07AF44C0-BBAC-4FC6-BE3E-980144DC35B8

P31

Q35221777-9571B289-0CBC-49F5-9B1A-342DE3AA01A7

P356

Q35221777-6DF70F5E-891A-43DB-8218-11B924718664

P407

Q35221777-26FCF479-F0AE-4142-AE1E-1B234FAC3BD8

P433

Q35221777-AA8553A5-A086-48FC-A54E-4F0F7C627CC3

P478

Q35221777-B6CE3565-5E8C-43CA-8C8B-DDE17485730D

P577

Q35221777-E2F91C79-ACC5-45DE-82AE-A7B1FFF7235C

P698

Q35221777-C75DCBB8-A846-4313-A4C2-440486EF28F7

P932

Q35221777-FDE8D897-557D-468D-AC39-7850CB30FEF1

P356

WJG.V21.I12.3509

P1433

World Journal of Gastroenterology

P1476

Effect of entacapone on colon ...... t model of Parkinson's disease

@en

P2093

Chen-Zhe Liu

http://www.w3.org/2001/XMLSchema#string

Jin-Xia Zhu

http://www.w3.org/2001/XMLSchema#string

Jing-Dong Xu

http://www.w3.org/2001/XMLSchema#string

Li-Fei Zheng

http://www.w3.org/2001/XMLSchema#string

Li-Sheng Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Feng

http://www.w3.org/2001/XMLSchema#string

Yue Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Levodopa in the treatment of Parkinson's disease: current status and new developments

Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI study.

COMT Val(158)Met genotypes differentially influence subgenual cingulate functional connectivity in healthy females.

Activation of submucosal 5-HT(3) receptors elicits a somatostatin-dependent inhibition of ion secretion in rat colon

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

A systematic review of catechol-0-methyltransferase inhibitors: efficacy and safety in clinical practice.

Electrolyte transport in the mammalian colon: mechanisms and implications for disease.

Effects of acute dopamine precusor depletion on immediate reward selection bias and working memory depend on catechol-O-methyltransferase genotype

Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.

Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

P304

3509-3518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I12.3509

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25834315

http://www.w3.org/2001/XMLSchema#string

P932

4375572

http://www.w3.org/2001/XMLSchema#string